Business Insights
Diagnostic Technologies
Diseases
Point-of-Care Testing
Research & Development
Sign In
Autoimmune
Cancer
Cardiovascular
COVID-19
Health Topics
Infectious
Health Topics
Genetic causes identified for three rare diseases
A computational approach helped identify previously unknown genetic causes of primary lymphedema, thoracic aortic aneurysm disease, and congenital deafness.
March 16, 2023
Bionano Laboratories launches new optical genome mapping tests
These tests offer genome-wide assessment of structural variants (SVs) and testing for most common and rare chromosomal abnormalities to assist clinicians in both diagnosing and managing their patients’ medical conditions.
March 15, 2023
Swedish study shows blood test may help in evaluating epilepsy
High levels of immune proteins before and after epileptic seizures may serve as epilepsy biomarkers that can be identified with a simple blood test.
March 14, 2023
DnaNudge, Mylab to develop MDx tests for diabetic foot infections, other health conditions
DnaNudge anticipates that its multiplex tests will enable health teams to identify the specific microbiological organisms responsible for each foot infection, providing antimicrobial resistance results in just over an hour.
March 13, 2023
Rowan University, Durin Technologies tout preliminary results for early Alzheimer's blood test
Using eight autoantibody biomarkers, the test identified the presence of Alzheimer's disease pathology across the disease's progression, including among those originally determined to have no trace of the disease, the researchers said.
March 8, 2023
AriBio, Fujirebio partner on biomarker development for Alzheimer’s, other neurodegenerative disorders
The agreement will provide Fujirebio access to clinical samples and data that have been collected in an ongoing phase III Alzheimer’s disease study being conducted by AriBio.
March 8, 2023
Most Popular
Genetic causes identified for three rare diseases
Researchers in study validate test to identify newborns with homocystinuria, a rare inherited disease
FDA reissues EUA for Janssen COVID-19 vaccine, includes warning about risks of myocarditis, pericarditis
Duke University researchers discover biomarkers may identify early pancreatic cancer risk
Netherlands researchers combine CRISPR, bioluminescence in proof-of-concept infectious disease test
Werfen completes $2B acquisition of Immucor, expands presence in specialized diagnostics
FDA grants clearance to Abbott for first commercial laboratory test to detect traumatic brain injury
The test runs on Abbott's Alinity i laboratory immunoassay instrument, providing a result in 18 minutes to help clinicians quickly assess concussion and triage patients, Abbott said. Negative results rule out the need for a CT scan.
March 7, 2023
Indiana University, MindX Sciences researchers developing blood test for anxiety
A blood test for anxiety may determine an individual’s risk of developing anxiety, and which therapies might treat it most effectively, the researchers said.
March 8, 2023
Study supports genetic testing for people with cerebral palsy
A meta-analysis of recent cerebral palsy research suggests that genetic testing could be offered as the standard procedure for people with the disorder.
March 7, 2023
Medicare paid $704.2M for drug testing at risk of noncompliance with requirements
In an audit, the Office of Inspector General identified Medicare Part B payments for drug testing services that were at risk for noncompliance with Medicare requirements.
March 1, 2023
Modifying messenger RNA provides new Alzheimer’s disease target
Reducing methylation of a key messenger RNA can promote macrophage migration into the brain and ameliorate Alzheimer’s disease symptoms in mice.
March 7, 2023
Quanterix Q4 revenues drop 15% but match analysts’ expectations
For full-year 2022, total revenue was $105.5 million, a decline of 5% compared with 2021 revenue that included $5.2 million in National Institutes of Health (NIH) Rapid Acceleration of Diagnostics (RADx) grant money.
March 6, 2023
Page 1 of 58
Next Page